InsidersTradesSigma
灵康药业: directors' dealings · France · AMF
SSE:603669FR·AMFMcap 3.3Bn€
Explore the full insider trade history of 灵康药业, a listed equity based in France. Shares are quoted on FR FR, under the authority of AMF. Market capitalisation: €3.3bn. The latest transaction was reported on 19 July 2021 — Sale. Among the most active insiders: 陶灵刚. All data is free.
1
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
1 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
4.36 €
Income statement
Revenue322.5 M€
Gross profit141.0 M€44% margin
Net income−193.2 M€-59.9% margin
Balance sheet & cash
Market cap3.29 Bn€
Total debt291.7 M€
Free Cash Flow−135.5 M€
Last declaration on 19 July 2021
Declarations0 total
No declarations found
0 of 0 declarations